This is an assay used in labs. Hmm...well, it doesn't go into much depth about it. It doesn't explain a protocol. It talks about both the ribonuclease mismatch cleavage, the chemical cleavage method, and enzyme cleavage method (all cleavage-based methods). Here is the summary:
"Several techniques exploit the fact that mismatched bases are sensitive to binding or cleavage by enzymes or chemicals. After PCR amplification, the wild-type and variant products are subjected to denaturation/renaturation to create heteroduplex molecules. After incubation with resolvases or chemicals, the products are resolved electrophoretically side by side to score for the presence of mismatch-cleaved DNAs. Cleavage methods mostly work on heteroduplex molecules, cleaving the helix at the distorted region caused by the mismatch. This means that homozygous or hemizygous mutations would not be detected unless the sample is hybridized with a reference sample to form the mismatched heteroduplex. These methods are able to scan larger fragments than conformation-based techniques, and the size of the cleaved product roughly indicates the localization of the mutation; however, they require considerable post-PCR manipulation."
It goes on to explain the different protocols:
"Ribonuclease mismatch cleavage: the single-strand specificity of RNase has been utilized to digest RNA:RNA or RNA:DNA heteroduplexes. The technique has been adapted to commercially available nonisotopic RNase cleavage assays (NIRCA) with higher mutation rates than in the original versions. However, the major drawback of these methods is that they require in vitro synthesis of RNA."
I just don't get how this could lead to detection of an SNP in vitro. How would ribonuclease know that a certain base is incorrect?
Ryan